Hansson, L., Asklid, A., Diels, J., Eketorp-Sylvan, S., Repits, J., Søltoft, F., . . . Österborg, A. (2017). Ibrutinib versus previous standard of care: An adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia. Ann Hematol.

Hansson, Lotta, Anna Asklid, Joris Diels, Sandra Eketorp-Sylvan, Johanna Repits, Frans Søltoft, Ulrich Jäger, and Anders Österborg. "Ibrutinib Versus Previous Standard of Care: An Adjusted Comparison in Patients With Relapsed/refractory Chronic Lymphocytic Leukaemia." Ann Hematol 2017.

Hansson, Lotta, et al. "Ibrutinib Versus Previous Standard of Care: An Adjusted Comparison in Patients With Relapsed/refractory Chronic Lymphocytic Leukaemia." Ann Hematol 2017.